STudy of Risk Assessment To reduce complications In patients Following noncardiac surgerY (STRATIFY)
STudy of Risk Assessment To reduce complications In patients Following noncardiac surgerY (STRATIFY)
批准号:
nhmrc : 351475
负责人:
Prof Bala Venkatesh
金额:
$29.07万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cardiac problems account for many complications in patients undergoing major non-cardiac surgery, and even apparently minor cardiac damage is a marker of high risk for subsequent adverse events. Unfortunately, while money and effort is expended on identifying patients at risk, the appropriate response to this risk is quite unclear. The performance of bypass surgery or balloon angioplasty in order to treat the underlying coronary disease of at-risk patients is used in other situations, and reduces longterm risk. However, in many patients undergoing major noncardiac surgery, this approach may be inappropriately aggressive, as these patients are often elderly, have other diseases that make heart operations more difficult and risky than usual, and in any case may have a reduced life expectancy from the disease necessitating the operation. As the most critical issue is to ensure that patients undergo their surgery uneventfully, an alternative is the use of intensive medical therapy to protect the heart. This multicentre study, based at Brisbane hospitals that perform large numbers of major operations, will follow up patients for complications, and outcome (including quality of life) will be assessed six months after the operation. We will address two important questions about the efficacy and cost of risk reduction strategies. First, in patients at higher levels of risk and with a positive stress test, could a combination of medical therapy designed to protect the heart be as effective as current approaches, which include the performance of bypass surgery or coronary balloon angioplasty? Second, in patients identified as being at some risk - but low risk - are drugs sufficiently effective to avoid the need for further testing to quantify risk? As the population continues to age, the numbers of at risk patients undergoing major surgery will increase, and answers to these questions will provide important information to guide their management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sepsis Outcomes Research
-
批准号:nhmrc : 1142494
-
项目类别:Practitioner Fellowships
-
资助金额:$18.59万
-
财政年份:2018
-
负责人:Prof Bala Venkatesh
-
依托单位:
Management of burn injury: Fluid dynamics and antibiotic pharmacokinetics
-
批准号:nhmrc : 351519
-
项目类别:NHMRC Project Grants
-
资助金额:$22.83万
-
财政年份:2005
-
负责人:Prof Bala Venkatesh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:潘军
-
依托单位:
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
-
批准号:81973152
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2019
-
负责人:胡东生
-
依托单位:
基于时间序列间分位相依性(quantile dependence)的风险值(Value-at-Risk)预测模型研究
-
批准号:71903144
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2019
-
负责人:张申
-
依托单位:
RISK通路在胃泌素介导的心脏缺血再灌注损伤保护中的作用研究
-
批准号:81800239
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:符金娟
-
依托单位:
异氟烷基于TLR4/RISK/NF-κB调控糖尿病缺血性脑卒中后NLRP3炎症小体形成的机制研究
-
批准号:81771232
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2017
-
负责人:张鸿飞
-
依托单位:
Notch1与RISK/SAFE/HIF-1α信号通路整合在I-postC保护中的作用及其机制
-
批准号:81260024
-
项目类别:地区科学基金项目
-
资助金额:50.0万元
-
批准年份:2012
-
负责人:刘季春
-
依托单位: